| Description | Odronextamab, a fully human, hinge-stabilized IgG4-based bispecific antibody, targets CD3 receptors on T cells and CD20 receptors on B cells [1]. |
| molecular weight | N/A |
| CAS | 1801338-64-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |